2015
DOI: 10.1186/s12891-015-0650-y
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of tonic spinal cord stimulation, high-frequency and burst stimulation in patients with complex regional pain syndrome: a double-blind, randomised placebo controlled trial

Abstract: BackgroundComplex Regional Pain Syndrome (CRPS) is a disabling disease that is sometimes difficult to treat. Although spinal cord stimulation (SCS) can reduce pain in most patients with CRPS, some do not achieve the desired reduction in pain. Moreover, the pain reduction can diminish over time even after an initially successful period of SCS. Pain reduction can be regained by increasing the SCS frequency, but this has not been investigated in a prospective trial. This study compares pain reduction using five S… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
24
0
2

Year Published

2015
2015
2022
2022

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 30 publications
(26 citation statements)
references
References 80 publications
0
24
0
2
Order By: Relevance
“…). Of these, 15 were articles (Table ) and 14 were abstracts/records of ongoing or unpublished studies (Supporting Information Table S3).…”
Section: Resultsmentioning
confidence: 99%
“…). Of these, 15 were articles (Table ) and 14 were abstracts/records of ongoing or unpublished studies (Supporting Information Table S3).…”
Section: Resultsmentioning
confidence: 99%
“…Reporting of the results is in accordance with the CONSORT statement (Schulz et al, 2010). The study protocol was registered in the Current Controlled Trials database (registration number ISRCTN 36655259) and was published in peer-reviewed journal that fully details the inclusion and exclusion criteria (Kriek et al, 2015b). A flowchart and an overview of all outcome parameters of the entire comprehensive study are provided in Supporting Information Fig.…”
Section: Study Design and Participantsmentioning
confidence: 99%
“…However, despite over 50 years of clinical utilization and research, our understanding of the mechanisms by which SCS diminishes pain is limited . Nevertheless, in animal models of neuropathic pain, SCS has been shown to inhibit the hyperexcitability of dorsal horn wide dynamic range neurons and induce the release of GABA in the dorsal horns of the spinal cord gray matter, which results in subsequent amelioration of glutamatergic neurotransmission . Our understanding of how SCS impacts pain processing mechanisms does not preclude a potentially efficacious set of effects in acute, subacute, and acute‐on‐chronic pain.…”
Section: Discussionmentioning
confidence: 99%